Kepa, Given these issues, wouldn't it be better for these SNIP WG-developed test files to be moved from Claredi's web site to the SNIP web-site with appropriate information about their source and caveats for use?
This would then allow Claredi to remove them from its web site and hopefully eliminate the negative perceptions and misuse/misunderstanding of the test files. Rachel Foerster -----Original Message----- From: Kepa Zubeldia [mailto:[EMAIL PROTECTED]] Sent: Saturday, August 10, 2002 12:47 PM To: Mark Charles; [EMAIL PROTECTED] Subject: Re: SNIP repository for test transactions Mark, Great list. I would like to add one concern of Claredi: - Negative impact: Concern that the users of the list will think this is the only data available for testing. This could result in a negative image for the transactions work group in general. It has already resulted in a negative image for Claredi, where uninformed visitors think that the only files that Claredi has for testing are the files available in the SNIP download pages. And they turn away. This happens way too frequently. There is also the potential liability of someone going to the site, downloading the test files, testing with all of them, and then thinking they are done. That is it, all they need to do. Now they think they are HIPAA compliant. When they find out they are not, they could end up pointing the finger to the testing sub-workgroup, or to the owner of the web site. That is another concern we have now. Kepa On Friday 09 August 2002 06:49 am, Mark Charles wrote: > As discussed in today's SNIP Testing SWG conference call, there are several concerns that must be overcome before providers and payers are willing to contribute their test transactions to a public repository. > > Here are concerns that have been mentioned so far. Please respond to the list serv with any additional concerns. > > Once we get a stable list of concerns, we can decide whether to address these in a future conference call, an informal get together in Chicago, or whatever. > > 1. Risk of adverse consequences. Concern that there will be adverse publicity, legal action, or that someone might use public test transactions to appeal billing or payment decisions. > > 2. Diversion of effort. Concern that the efforts required to de-identify, catalog and submit test cases to the repository will divert staff from core tasks. > > 3. Confusion about level of compliance. Concern that test transactions might be inaccurately identified as to level of compliance. > > 4. Confusion about description. Concern that test transactions might be inaccurately described as to line of business, payer-specific requirements, etc. > > 5. Allocation of benefits. Concern that a vendor or someone else will get the credit for hard work done by the contributor. > > Mark Charles > Michigan Department of Public Health (Medicaid) > (517) 241-7766 > [EMAIL PROTECTED] > > Please note that it may take up to 72 hours to process your request. > <P>The WEDI SNIP listserv to which you are subscribed is not moderated. The > discussions on this listserv therefore represent the views of the individual > participants, and do not necessarily represent the views of the WEDI Board of > Directors nor WEDI SNIP. If you wish to receive an official opinion, post > your question to the WEDI SNIP Issues Database at > http://snip.wedi.org/tracking/. > Posting of advertisements or other commercial use of this listserv is > specifically prohibited. > > -- This email contains confidential information intended only for the named addressee(s). Any use, distribution, copying or disclosure by any other person is strictly prohibited. Please note that it may take up to 72 hours to process your request. <P>The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. Posting of advertisements or other commercial use of this listserv is specifically prohibited. Please note that it may take up to 72 hours to process your request. <P>The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. Posting of advertisements or other commercial use of this listserv is specifically prohibited.
